Perispinal etanercept: Potential as an Alzheimer therapeutic
-
Correspondence: W Sue T Griffin griffinsuet@uams.edu
Journal of Neuroinflammation 2008, 5:3 doi:10.1186/1742-2094-5-3
Accesses
- Last 30 days: 446 accesses
- Last year: 4497 accesses
- All time: 44811 accesses
Cited by
BioMed Central: 1 citation
|
Research article
Edward L Tobinick, Hyman Gross BMC Neurology 2008, 8:27 (21 July 2008) Two case reports and further data from a phase II clinical trial support the use of peri-spinal administration of the TNF-alpha inhibitor etanercept to improve verbal abilities in patients with Alzheimer’s disease.
|
